Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shanghai Taichu Biotechnology

Request full access

A company leading the non-clinical research of new drugs to Contract Development and Manufacturing Organization (CDMO) production

ChinaFounded 2020Biotech & Life Sciences

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
12.3/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC May 2023 $48M $193M Apricot Capital · Seasonal investment · Aopeng Investment · IDG Capital ↗
SEEDEquity / VC Aug 2022 $41M $165M Lingang Blue Bay Fund —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shanghai Taichu Biotechnology in its local ecosystem

Live from Dealroom

The Shanghai Taichu Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

  • SIIC Investment
  • Taifu Capital
  • Lingang Blue Bay Fund

Series A12 investors entered at this stage

  • IDG Capital
  • Apricot Capital
  • Seasonal investment
  • Aopeng Investment
  • Yijing Capital
  • Xingzhi Capital
  • Juntong Capital
  • SHC Shanghai Biomedical Fund
  • Boquan Capital
  • Shanghai Science and Technology Fund
  • Lula Capital
  • Zhongxin Capital

Other known investors1 additional known investor

  • Shanghai Institute of Pharmaceutical Industry
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shanghai Taichu Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shanghai Taichu Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.